Credits: 0.25 AMA PRA Category 1 Credits™

Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-124

Overview: When patients with T2DM have difficulty controlling their glucose with standard approaches, or are newly diagnosed but severely hyperglycemic, insulin is commonly used to help control their metabolism. Using long acting, once a day agents is a standard of care but in the last 15 years, the costs of insulin has skyrocketed. During this episode we will review a study examining the effects of using Neutral Protamine Hagedorn Insulin (NPH) rather than once a day insulin on A1c control and risk for hypoglycemia and discuss their findings, which suggest NPH can be used with equivalent glycemic control and with no additional risk.

Guest: Alan M. Ehrlich, MD, FAAFP

Music Credit: Richard Onorato